866-326-3365 
Gabapentin withdrawal is a real and potentially dangerous syndrome that occurs in anyone who stops taking the drug abruptly after a period of regular use, whether prescribed or not. Symptoms begin within 12 to 48 hours of the last dose and include severe anxiety, insomnia, tremors, disorientation, and — in serious cases — seizures.
Despite a reputation for being safer than benzodiazepines, gabapentin (brand name Neurontin) has well-documented potential for dependence, misuse, and a difficult withdrawal syndrome that requires medical management. Knowledge of the timeline, severity drivers, and danger signals is foundational for anyone who takes gabapentin regularly or offers care for a person who does.
Key Highlights
- Gabapentin withdrawal begins in as little as 12 hours: Onset varies from 12 hours to 7 days after the last dose, depending on dose, duration, and individual factors; symptoms typically peak around day 3 (Mersfelder & Nichols, 2016).
- Misuse rates are higher in addiction treatment populations: Surveys indicate that approximately 1.1% of the general population and 22% of people in drug abuse treatment centers have misused gabapentin — a more than 20-fold difference that reflects the drug’s elevated appeal to people with existing substance use disorders (Mersfelder & Nichols, 2016).
- The FDA issued a drug safety warning for gabapentin in 2019: The FDA warned that serious — and potentially fatal — breathing difficulties occur when gabapentin is combined with opioids, benzodiazepines, or other CNS depressants, a combination increasingly seen in misuse contexts (FDA, 2019).
- Virtually all documented addiction cases involved prior substance use history: A review of 18 case reports found that every case of gabapentin addiction occurred in a patient with a history of alcohol, cocaine, or opioid misuse — making this population the highest-risk group (Mersfelder & Nichols, 2016).
- A gradual taper is the foundation of safe gabapentin discontinuation: Abrupt stoppage — particularly at high doses — raises the risk of severe withdrawal and seizures; a medically supervised taper over at least one week, and often longer, is strongly recommended (Hellwig et al., 2010).
What Is Gabapentin and Why Does Withdrawal Happen?
Gabapentin withdrawal happens because the brain physically adapts to the drug’s presence over time, and when it is suddenly removed, that adaptation produces a rebound of neurological excitation that the brain no longer suppresses.
Gabapentin (brand names Neurontin, Gralise, Horizant) is an anticonvulsant approved by the FDA in 1993 for partial seizures and postherpetic neuralgia, and extensively prescribed off-label for neuropathic pain, fibromyalgia, anxiety, and alcohol withdrawal, making it one of the most widely prescribed medications in the United States (Yasaei et al., 2024).
Gabapentin’s exact mechanism of action is not fully understood, but it is known to bind to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. This lowers the release of excitatory neurotransmitters, the brain’s signalling chemicals that drive activity.
The net effect is a calming, inhibitory action that makes the drug effective for seizures and pain, but also means that with repeated use, the brain adapts by accelerating its own excitatory activity to compensate. When gabapentin is suddenly removed, that compensatory excitation is no longer balanced, producing the anxiety, tremors, restlessness, and in severe cases seizures that characterise withdrawal.
Unlike benzodiazepines or opioids, gabapentin is not federally classified as a controlled substance. However, several U.S. states, Kentucky, Michigan, Tennessee, and Virginia, have placed it under Schedule V scheduling due to mounting evidence of misuse and diversion.
A 2016 systematic review found gabapentin misuse across healthcare settings, emergency departments, and among people who use opioids, groups where it is obtained illicitly and used to potentiate opioid effects (Smith et al., 2016).
What Are the Symptoms of Gabapentin Withdrawal?
The symptoms of gabapentin withdrawal fall into two categories: common symptoms that occur across most cases, and severe symptoms that emerge at high doses or with abrupt cessation, covering seizures, delirium, and respiratory depression. Severity is determined primarily by dose, duration of use, and whether other CNS depressants are involved.
Common Withdrawal Symptoms
- Anxiety and agitation: The first and most prominent symptom, driven by the brain’s excitatory rebound after gabapentin is removed
- Insomnia: Difficulty falling or staying asleep, frequently severe in the early withdrawal period
- Sweating and diaphoresis: Autonomic nervous system instability produces excessive perspiration, often accompanied by chills
- Nausea and abdominal discomfort: Gastrointestinal symptoms are common in the early days of withdrawal
- Headache: Persistent, often daily headaches are reported frequently during gabapentin withdrawal
- Tremors: Fine or coarse shaking, typically involving the hands, reflects neurological excitability
- Rapid heart rate and elevated blood pressure: Cardiovascular autonomic instability mirrors the pattern seen in benzodiazepine and alcohol withdrawal
- Confusion and disorientation: Cognitive disruption that swings from mild cloudiness to frank delirium in severe cases
- Sensitivity to light and sound (photophobia/phonophobia): Sensory hypersensitivity reflecting CNS excitatory overactivity
- Irritability and mood instability: Extreme Emotional dysregulation, particularly in the peak phase
Begin your journey to recovery with personalized drug & alcohol rehab—verify your insurance coverage in under a minute. Check your coverage online now.
Severe Withdrawal Symptoms
Severe gabapentin withdrawal symptoms include seizures, delirium, hallucinations, and respiratory depression — all of which are life-threatening and are most likely in patients on high doses who stop abruptly (Hellwig et al., 2010).
- Seizures: Arguably the most serious withdrawal risk — gabapentin withdrawal seizures have been documented in the literature even in patients undergoing a formal taper, highlighting the need for close medical supervision
- Delirium: Severe confusion with disorientation, psychomotor agitation, and perceptual disturbances that require ICU-level care
- Hallucinations: Primarily visual or tactile in nature; less common than in alcohol withdrawal but documented in gabapentin cases
- Respiratory depression: Particularly when gabapentin withdrawal occurs in someone also using opioids or other CNS depressants, the FDA has identified fatal respiratory events in this context
Gabapentin withdrawal symptoms range from anxiety and insomnia to seizures and delirium — severity depends on dose, duration of use, and individual risk factors.
What Is the Gabapentin Withdrawal Timeline?
The gabapentin withdrawal timeline typically begins within 12 to 48 hours of the last dose, peaks around day 3, and resolves for most patients by day 7 to 10, though high-dose or long-term users experience protracted symptoms lasting weeks to months (Mersfelder & Nichols, 2016; Hellwig et al., 2010).
| Timeframe | Phase | Typical Symptoms |
|---|---|---|
| 12-48 hours after last dose | Onset | Anxiety, restlessness, insomnia, sweating, nausea, headache, irritability; symptoms begin and gradually intensify |
| Day 3 | Peak | Symptoms are most severe: agitation, disorientation, confusion, tremors, rapid heart rate, elevated blood pressure; seizure risk is highest in this window |
| Days 5-7 | Declining | Confusion and agitation begin to subside; anxiety, headaches, and sensitivity to light and sound may persist |
| Days 7-10 | Late resolution | Most physical symptoms resolve; fatigue and mood disturbance may linger; most patients report major improvement by day 10 |
| Weeks to months (some patients) | Protracted | Residual anxiety, insomnia, and dysphoria persist for weeks or months in people who used high doses for extended periods |
The timeline above describes typical gabapentin withdrawal in a person without other complicating substances or medical conditions. People who also use opioids, benzodiazepines, or alcohol may experience a more complex and prolonged withdrawal course, with overlapping withdrawal syndromes that require specialised medical management in a medical detox facility.
What Factors Affect the Severity of Gabapentin Withdrawal?
The factors that most affect the severity of gabapentin withdrawal are: daily dose, duration of use, whether discontinuation was abrupt, concurrent use of opioids or benzodiazepines, a pre-existing seizure disorder, prior substance use history, and kidney function. Clinicians assess all of these before recommending a discontinuation strategy.
| Risk Factor | Why It Affects Severity |
|---|---|
| High daily dose | Patients taking more than 3,000 mg/day are at a greater risk of severe withdrawal and seizures; the majority of documented dependence cases involved doses of 600–8,000 mg/day |
| Long duration of use | The longer the brain has adapted to gabapentin’s presence, the longer and more complex the withdrawal process tends to be |
| Abrupt discontinuation | Stopping cold turkey gives the nervous system no time to readjust; tapering is always recommended to minimize risk |
| Concurrent opioid use | Gabapentin with opioids dramatically amplifies CNS depression risk; co-use is a major driver of fatal overdose reports and complicates the withdrawal profile |
| Concurrent benzodiazepine use | Overlapping CNS depressants produce additive withdrawal complexity and increase seizure and respiratory risk |
| Pre-existing seizure disorder | People taking gabapentin for epilepsy are at particular risk if the drug is abruptly stopped, since it is being used to suppress seizure activity |
| History of substance use disorder | A prior history of alcohol, opioid, or cocaine use disorder is present in virtually all documented gabapentin addiction cases and predicts a more difficult withdrawal |
| Impaired kidney function | Gabapentin is excreted almost entirely unchanged by the kidneys; impaired renal clearance causes the drug to accumulate and prolongs its elimination, altering the withdrawal timeline |
| Older age | Age-related decreases in renal function slow gabapentin clearance, and older adults tend to have lower physiological reserve to manage withdrawal stress |
Is Gabapentin Withdrawal Dangerous?
Yes, gabapentin withdrawal is life-threatening in certain circumstances. The most grave risks are seizures and respiratory depression, both of which have resulted in death. Gabapentin withdrawal poses severe seizure and respiratory risks that necessitate strict clinical supervision rather than solo attempts at tapering.
Abruptly removing the drug sparks rebound seizures or even status epilepticus, a risk that persists even during formal dose reductions (Hellwig et al., 2010).
Furthermore, the Food and Drug Administration (FDA) has warned that gabapentinoids cause life-threatening respiratory depression, particularly when combined with opioids or other CNS (central nervous system) depressants, a danger evidenced by 12 reported deaths among high-risk patients (FDA, 2019). These compounded neurological and respiratory threats reinforce the clinical necessity of a medically managed taper for anyone with dependence.
Contact us today to schedule an initial assessment. We are here to help.
How Is Gabapentin Withdrawal Treated?
Gabapentin withdrawal is treated through three components: a medically supervised dose taper, inpatient detox for higher-risk patients, and integrated addiction treatment addressing any co-occurring substance use disorder. For people with concurrent substance use disorders, integrated dual diagnosis treatment that addresses both the gabapentin dependence and the underlying condition is essential.
Medically Supervised Tapering
The cornerstone of gabapentin withdrawal treatment is a gradual, supervised dose reduction. Rather than stopping abruptly, a physician develops an individualised taper schedule that progressively reduces the gabapentin dose by no more than 25% of the current dose per week, allowing the brain time to recalibrate at each new level. The pace is guided by the patient’s symptoms, medical history, and risk factors: someone who has been taking 3,600 mg daily for three years requires a much slower, more carefully managed taper than someone on 600 mg for six months (Hellwig et al., 2010).
Clinical guidance suggests taper schedules should last a minimum of one week for lower-risk cases, with higher-risk patients, particularly those with a history of withdrawal seizures or concurrent substance use, requiring taper periods of several months. The physician reassesses regularly and adjusts the pace if withdrawal symptoms become unmanageable or if complications arise.
Medical Detox
For patients at higher risk — those on very high doses, those with concurrent opioid or benzodiazepine dependence, or those who have previously experienced withdrawal seizures — a structured inpatient medical detox program provides around-the-clock monitoring and the ability to intervene rapidly if complications develop.
In the detox setting, additional medications are utilized to manage specific withdrawal symptoms. Benzodiazepines such as lorazepam are used to lower seizure risk and manage severe agitation. Clonidine, an alpha-2 agonist, addresses cardiovascular autonomic symptoms such as rapid heart rate and elevated blood pressure.
Addressing Co-Occurring Substance Use
Because virtually all documented cases of gabapentin addiction occur in people with a concurrent or prior substance use disorder, most involving opioids, alcohol, or cocaine, treating only the gabapentin dependence without addressing the underlying addiction dramatically increases relapse risk (Mersfelder & Nichols, 2016).
Comprehensive residential treatment that integrates medical detox with evidence-based addiction therapy, cognitive behavioural therapy, and relapse prevention planning gives patients the best chance of sustained recovery.
Effective gabapentin withdrawal treatment combines a gradual dose taper, 24/7 medical supervision, and integrated addiction care for the best outcomes.
Are you covered for treatment?
Carolina Center for Recovery works with most major insurance providers to make high-quality care accessible and affordable.
Check Coverage Now!Frequently Asked Questions
Can you die from gabapentin withdrawal?
Yes — in severe cases, gabapentin withdrawal can be fatal. The primary risks are withdrawal seizures, which are life-threatening if untreated, and respiratory depression, which is especially dangerous in people who are also using opioids or other sedatives. The FDA has identified fatal respiratory events involving gabapentin and CNS depressants in postmarket surveillance data (FDA, 2019). This is why medically supervised detox is strongly recommended for anyone with gabapentin dependence.
How long does gabapentin withdrawal last?
Most people experience the most acute symptoms in the first 3 to 7 days, with improvement by day 10. The duration varies considerably based on dose, duration of use, and individual factors. Some patients, particularly those who have used high doses for extended periods, report lingering symptoms including anxiety, insomnia, and mood disturbances for weeks or months after the acute phase resolves. This is sometimes referred to as protracted withdrawal.
Rediscover Life at Carolina Center for Recovery
At Carolina Center for Recovery, we’re here to help you or your loved one take the first step toward lasting recovery and a brighter future.
Our Team
Can withdrawal happen even if I take gabapentin exactly as prescribed?
Yes. Withdrawal is a physiological response to the absence of a substance the body has adapted to; it is not a sign of addiction or misuse. Patients who take gabapentin exactly as prescribed at therapeutic doses develop physical dependence, particularly with regular long-term use. If you are considering stopping gabapentin, speak with your prescribing physician first; a supervised taper is appropriate even for patients without a substance use history.
Is gabapentin a controlled substance?
Gabapentin is not a federally controlled substance in the United States. Given mounting evidence of misuse and diversion, especially among people with opioid use disorder, a growing number of states have added it to their controlled substance schedules at the state level, most commonly as Schedule V. This means monitoring requirements and prescription restrictions vary depending on where you live. The FDA has required manufacturers to conduct studies on gabapentin’s abuse potential, particularly in combination with opioids (FDA, 2019).
What is the difference between gabapentin dependence and gabapentin addiction?
The difference between gabapentin dependence and gabapentin addiction is that dependence involves a physical adaptation resulting in withdrawal symptoms. In contrast, addiction is a complex behavioral condition marked by compulsive use and loss of control.
While dependence occurs in patients taking the medication exactly as prescribed, the risk of true addiction is higher for individuals with a history of substance use disorders; research indicates that nearly all documented cases of gabapentin addiction involved a prior history of opioid, alcohol, or cocaine misuse (Mersfelder & Nichols, 2016). Regardless of whether a patient is experiencing dependence or addiction, professional medical supervision remains essential to navigate the withdrawal process safely.
Begin your journey to recovery with personalized drug & alcohol rehab—verify your insurance coverage in under a minute. Check your coverage online now.
Summary
Gabapentin withdrawal is a serious medical condition with a well-documented clinical profile — symptoms that comprise seizures, delirium, and respiratory depression mean it should never be managed alone, regardless of whether the drug was prescribed or obtained illicitly.
If you or someone you care about needs help stopping gabapentin safely, South Carolina Addiction Treatment offers medically supervised detox and integrated residential treatment designed to manage withdrawal safely and address the underlying causes of substance misuse. Contact our admissions team today — same-day admissions are available.
References
Food and Drug Administration. (2019, December 19). FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR). https://www.fda.gov/safety/medical-product-safety-information/neurontin-gralise-horizant-gabapentin-and-lyrica-lyrica-cr-pregabalin-drug-safety-communication
Hellwig, T. R., Hammerquist, R., & Termaat, J. (2010). Withdrawal symptoms after gabapentin discontinuation. American Journal of Health-System Pharmacy, 67(11), 910–912. https://doi.org/10.2146/ajhp090313
Mersfelder, T. L., & Nichols, W. H. (2016). Gabapentin: Abuse, dependence, and withdrawal. The Annals of Pharmacotherapy, 50(3), 229–233. https://doi.org/10.1177/1060028015620800
Smith, R. V., Havens, J. R., & Walsh, S. L. (2016). Gabapentin misuse, abuse and diversion: A systematic review. Addiction, 111(7), 1160–1174. https://doi.org/10.1111/add.13324
Yasaei, R., Katta, S., Patel, P., & Saadabadi, A. (2024, February 21). Gabapentin. In StatPearls [Internet]. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK493228/
